Investing to become financially independent
Investing to become financially independent
Discover the detailed analysis of Novartis, the pharmaceutical giant born from the merger of Ciba-Geigy and Sandoz, and its dividend policy that raises ethical and economic questions. Between job cuts and sustainable dividend growth, let's explore how this global leader in pharma balances its social responsibilities and financial performance.
Discover the history and activities of Nestlé, the Swiss food giant that is constantly innovating in the areas of human and animal nutrition. From its iconic bird's nest logo to its recent initiatives in health nutrition, Nestlé positions itself as a global leader combining tradition and innovation.
It's snowing hard as an annuitant gazes from his bedroom at his snow-covered car, reflecting on his privileged life and lucrative investments. Between growing dividends and free time to enjoy the pleasures of winter, this story illustrates the daily life of an investor who has managed to grow his capital without physical effort.
Myths surrounding foreign currency investing can lead to costly mistakes, especially in an environment where traditional economic fundamentals no longer dictate prices. Learn about the current realities of the foreign exchange market and how to avoid common pitfalls, particularly when it comes to the Swiss franc and its safe haven status.
Foreign currency actions and currency risk (1/4) Read More »
Dover Corporation is a major American industrial conglomerate with four business segments, including Engineered Systems, which specializes in heating, cooling and product identification systems. Despite its sensitivity to economic cycles, the company stands out for its attractive dividend policy and steady growth, offering an attractive investment opportunity with good protection against dollar fluctuations.
Bell, the Swiss leader in the meat sector and a major supplier to the wholesale trade, catering and food industry, employs over 9,000 people and enjoys a strong presence in Europe through its subsidiaries Polette, ZIMBO and Abraham. Despite the challenges of the euro fluctuations, the company maintains a solid performance with an increasing net profit and a successful diversification strategy, particularly in Russia, while maintaining a dominant position in its domestic market Switzerland.
CR Bard, a global leader in medical technology, is experiencing significant growth in the oncology sector despite a recent decline in its shares. Despite mixed financial results, the company maintains a solid position with good international exposure and stable financial ratios.
The first decade of the 21st century was marked by high stock market volatility, with the S&P making dramatic highs and lows. Learn how to navigate this volatile market and how to invest in more stable stocks that pay consistent dividends, including consumer and healthcare sectors.
Français